Inovio Investors Face April 7 Deadline in Securities Fraud Case Over Device, Drug Claims
Rosen Law Firm urges Inovio Pharmaceuticals investors with losses exceeding $100K to file claims before April 7, 2026 deadline in ongoing securities class action lawsuit.
INOinvestor lossessecurities class action
